Comparative study of the pharmacokinetics of MTX in juvenile idiopathic arthritis patients receiving long-term MTX monotherapy or MTX plus chloroquine

Journal of Clinical Pharmacy and Therapeutics

Volumn 32, Issue 6, 2007, Pages 579-584

  Kimura, E ^a   Oga, S ^b   Pereira, R M R ^b  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chloroquine; Juvenile idiopathic arthritis; Methotrexate; Pharmacokinetics

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLOID; ASPARTATE AMINOTRANSFERASE; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CHLOROQUINE; FIBRINOGEN; GLYCOPHORIN A; METHOTREXATE;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DRUG EFFECT; DRUG HALF LIFE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; JOINT SWELLING; JUVENILE RHEUMATOID ARTHRITIS; MALE; MONOTHERAPY; MORNING STIFFNESS; OUTCOME ASSESSMENT; PAIN ASSESSMENT; SCHOOL CHILD; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTIRHEUMATIC AGENTS; AREA UNDER CURVE; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHLOROQUINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; METHOTREXATE;

EID: 36248965625     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2007.00860.x     Document Type: Article

References (30)

1. Ilowite NT (2002) Current treatment of juvenile rheumatoid arthritis. Pediatrics, 109, 109 115.
2. Cronstein BN (2005) Low-dose methotrexate: a mainstay in the treatment of rheumatoid. Pharmacological Reviews, 57, 163 172.
3. Ramanan AV, Whitworth P, Baildam EM (2001) Use of methotrexate in juvenile idiopathic arthritis. Archives of Disease in Childhood, 88, 197 200.
4. O'Dell JR, Leff R, Paulsen G et al. (2002) Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications. Results of a two-year, randomized, double blind, placebo controlled trial. Arthritis and Rheumatism, 46, 1164 1170.
5. Tett SE, Cutler D, Day RO, Brown KF (1988) A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers. British Journal of Clinical Pharmacology, 26, 303 313.
6. Tett SE, Cutler D, Day R (1990) Antimalarials in rheumatic diseases. Baillieres Clinical Rheumatology, 4, 467 489.
7. Bensen W, Bensen W (1999) Aim for remission or "personal best" using combination DMARD therapy with methotrexate and hydroxychloroquine. Clinical Experimental Rheumatology, 17, S95 S101.
8. Trnavsky K, Gatterova J, Linduskova M, Peliskova Z (1993) Combination therapy with hydroxychloroquine and methotrexate in rheumatoid arthritis. Zeitschrift fur Rheumatologie, 52, 292 296.
9. Fries JF, Singh G, Lenert LE, Furst D (1990) Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis. Arthritis and Rheumatism, 33, 1611 1619.
10. Seideman P, Albertoni F, Beck O, Eksborg S, Peterson C (1994) Chloroquine reduces the bioavailability of methotrexate in patients with rheumatoid arthritis. Arthritis and Rheumatism, 37, 830 833.
11. Lafforgue P, Monjanel-Mouterde S, Durand A, Catalin J, Acquaviva PC (1995) Lack of correlation between pharmacokinetics and efficacy of low dose methotrexate in patients with rheumatoid arthritis. Journal of Rheumatology, 22, 844 849.
12. Carmichael SJ, Beal J, Day RO, Tett SE (2002) Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate. Journal of Rheumatology, 29, 2077 2083.
13. Wallace CA, Bleyer WA, Sherry DD, Salmonson KL, Wedgwood RJ (1989) Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis. Arthritis and Rheumatism, 32, 677 681.
14. Truckenbrodt H, Hafner R (1986) Methotrexate therapy in juvenile rheumatoid arthritis: a retrospective study. Arthritis and Rheumatism, 29, 801 807.
15. Wiela-Hojenska A, Orzechowska-Juzwenko K, Swierkot J, Wiland P, Hurkacz M, Szechinski J (2004) Monitoring methotrexate therapy in patients with rheumatoid arthritis. International Journal of Clinical Pharmacology and Therapeutics, 42, 434 441.
16. Ritschell WA (1989) Handbook of basic pharmacokinetics, 4th edn. Hamilton, IL : Drug Intelligence Publications.
17. Clegg DO, Dietz F, Duffy J et al. (1997) Safety and efficacy of hydroxychloroquine as maintenance therapy for rheumatoid arthritis after combination therapy with methotrexate and hydroxychloroquine. Journal of Rheumatology, 4, 1896 1902.
18. Wijnands MJ, Van Riel PL, Gribmau FW, Van De Putte LB (1990) Risk factors of second-line antirheumatic drugs in rheumatoid arthritis. Seminars in Arthritis and Rheumatism, 19, 337 352.
19. Mackenzie AH (1983) Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials. American Journal of Medicine, 75, 40 45.
20. Mavrikakis I, Sfikakis PP, Mavrikakis E, Rougas K, Nikolaou A, Kostopoulos C, Mavrikakis M (2003) The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine. A reappraisal. Ophthalmology, 110, 1321 1326.
21. Hashkes PJ, Balistreri WF, Bove KE, Ballard ET, Passo MH (1997) The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis. Arthritis and Rheumatism, 40, 2226 2234.
22. Landewé RB, Vergouwen MS, Goeei The SG, Van Rijthoven AW, Breedveld FC, Dijkmans BA (1995) Antimalarial drug induced decrease in creatinine clearance. Journal of Rheumatology, 22, 34 37.
23. Seideman P, Muller-Suur R, Ekman E (1993) Renal effects of low dose methotrexate in rheumatoid. Journal of Rheumatology, 20, 1126 1128.
24. Kremer JM, Petrillo GE, Hamilton RA (1995) Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy. Journal of Rheumatology, 22, 38 40.
25. Kimura E, Bersani-Amado CA, Igarashi K (2007) Inhibition of cell growth and polyamine levels in lymphocytes caused by the combination of methotrexate and Chloroquine. Latin American Journal of Pharmacy, 26, 424 427.
26. Kimura E, Nishimura K, Sakata K, Oga S, Kashiwagi K, Igarashi K (2004) Methotrexate differentially affects growth of suspension and adherent cells. International Journal of Biochemistry and Cell Biology, 36, 814 825.
27. Bannwarth B, Labat L, Moride Y, Schaeverbeke T (1994) Methotrexate in rheumatoid arthritis. An update. Drugs, 47, 25 50.
28. Bannwarth B, Pehourcq F, Schaeverbeke T, Dehais J (1996) Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis. Clinical Pharmacokinetics, 30, 194 210.
29. Croinstein BN (1995) The antirheumatic agents sulphasalazine and methotrexate share an anti-inflammatory mechanism. British Journal of Rheumatology, 34, 30 32.
30. Angelis-Stoforidis P, Vadja FJ, Christophidis N (1999) Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis. Clinical Experimental Rheumatology, 17, 313 320.